Unknown

Dataset Information

0

Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells.


ABSTRACT: Allogeneic T cell platforms utilizing induced pluripotent stem cell (iPSC) technology exhibit significant promise for the facilitation of adoptive immunotherapies. While mature T cell receptor (TCR) signaling plays a crucial role in generating T cells from iPSCs, the introduction of exogenous mature TCR genes carries a potential risk of causing graft-versus-host disease (GvHD). In this study, we present the development of truncated TCRα and TCRβ chains, termed mini-TCRs, which lack variable domains responsible for recognizing human leukocyte antigen (HLA)-peptide complexes. We successfully induced cytotoxic T lymphocytes (CTLs) from iPSCs by employing mini-TCRs. Combinations of TCRα and TCRβ fragments were screened from mini-TCR libraries based on the surface localization of CD3 proteins and their ability to transduce T cell signaling. Consequently, mini-TCR-expressing iPSCs underwent physiological T cell development, progressing from the CD4 and CD8 double-positive stage to the CD8 single-positive stage. The resulting iPSC-derived CTLs exhibited comparable cytokine production and cytotoxicity in comparison to that of full-length TCR-expressing T lymphocytes when chimeric antigen receptors (CARs) were expressed. These findings demonstrate the potential of mini-TCR-carrying iPSCs as a versatile platform for CAR T cell therapy, offering a promising avenue for advancing adoptive immunotherapies.

SUBMITTER: Takayanagi SI 

PROVIDER: S-EPMC10562677 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells.

Takayanagi Shin-Ichiro SI   Wang Bo B   Hasegawa Saki S   Nishikawa Satoshi S   Fukumoto Ken K   Nakano Kohei K   Chuganji Sayaka S   Kato Yuya Y   Kamibayashi Sanae S   Minagawa Atsutaka A   Kunisato Atsushi A   Nozawa Hajime H   Kaneko Shin S  

Molecular therapy. Methods & clinical development 20230916


Allogeneic T cell platforms utilizing induced pluripotent stem cell (iPSC) technology exhibit significant promise for the facilitation of adoptive immunotherapies. While mature T cell receptor (TCR) signaling plays a crucial role in generating T cells from iPSCs, the introduction of exogenous mature TCR genes carries a potential risk of causing graft-versus-host disease (GvHD). In this study, we present the development of truncated TCRα and TCRβ chains, termed mini-TCRs, which lack variable doma  ...[more]

Similar Datasets

| S-EPMC3245295 | biostudies-literature
| S-EPMC3464077 | biostudies-literature
| S-EPMC10173856 | biostudies-literature
| S-EPMC11762477 | biostudies-literature
| S-EPMC8422924 | biostudies-literature
| S-EPMC7876031 | biostudies-literature
| S-EPMC9522500 | biostudies-literature
| S-EPMC5380716 | biostudies-literature
| S-EPMC4608011 | biostudies-other
| S-EPMC5506104 | biostudies-literature